Aetiology of bacterial meningitis in infants aged <90 days : Prospective surveillance in Luanda, Angola by Pelkonen, Tuula et al.
International Journal of Infectious Diseases 97 (2020) 251–257Aetiology of bacterial meningitis in infants aged <90 days:
Prospective surveillance in Luanda, Angola
Tuula Pelkonena,b,*, Suvi Urttia, Elizabete dos Anjosb, Ondina Cardosob,
Linda de Gouveiac, Irmeli Roined, Heikki Peltolaa, Anne von Gottbergc,e,
Moe H. Kyawf
aChildren’s Hospital, Helsinki University Central Hospital, Helsinki, Finland
bHospital Pediátrico David Bernardino (HPDB), Luanda, Angola
cCentre for Respiratory Disease and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), Division of the National Health Laboratory
Service (NHLS), Johannesburg, South Africa
d Faculty of Medicine, University Diego Portales, Santiago, Chile
e School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
f Sanofi Pasteur, Epidemiology, Swiftwater, PA, USA
A R T I C L E I N F O
Article history:
Received 13 May 2020
Received in revised form 2 June 2020
Accepted 5 June 2020
Keywords:
Bacterial meningitis
Neonatal
Angola
Africa
Surveillance
Drug resistance
A B S T R A C T
Background: Despite effective antibiotics and vaccines, bacterial meningitis (BM) remains one of the
leading causes of morbidity and mortality in young infants worldwide. Data from Africa on the aetiology
and antibiotic susceptibility are scarce.
Objective: To describe the aetiology of BM in Angolan infants <90 days of age.
Methods: A prospective, observational, single-site study was conducted from February 2016 to October
2017 in the Paediatric Hospital of Luanda. All cerebrospinal fluid samples (CSF) from infants aged <90
days with suspected BM or neonatal sepsis were assessed. The local laboratory performed microscopy,
chemistry, culture, and susceptibility testing. PCR for vaccine-preventable pathogens was performed in
Johannesburg, South Africa.
Results: Of the 1287 infants, 299 (23%) had confirmed or probable BM. Of the 212 (16%) identified bacterial
isolates from CSF, the most common were Klebsiella spp (30 cases), Streptococcus pneumoniae (29 cases),
Streptococcus agalactiae (20 cases), Escherichia coli (17 cases), and Staphylococcus aureus (11 cases). A fifth
of pneumococci (3/14; 21%) showed decreased susceptibility to penicillin, whereas methicillin-resistant
S. aureus (MRSA) was encountered in 4/11 cases (36%). Of the gram-negative isolates, 6/45 (13%) were
resistant to gentamicin and 20/58 (34%) were resistant to third-generation cephalosporins. Twenty-four
percent (33/135) of the BM cases were fatal, but this is likely an underestimation.
Conclusions: BM was common among infants <90 days of age in Luanda. Gram-negative bacteria were
predominant and were often resistant to commonly used antibiotics. Continued surveillance of the
antibiogram is pivotal to detect potential changes without delay.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Meningitis Collaborators, 2018GBD 2016 Meningitis Collaborators,
2018). Although the incidence, aetiology, and outcome vary by age
and region (Edmond et al., 2010; GBD 2016 Meningitis Collabo-
rators, 2018; Oordt-Speets et al., 2018), the burden is heaviest in
Sub-Saharan Africa where the problem is related to poverty (GBD
2016 Meningitis Collaborators, 2018GBD 2016 Meningitis Collab-
orators, 2018). Outside Neisseria meningitidis epidemics, the peak
age of BM is in the neonatal period (GBD Meningitis Collaborators,
2018; GBD 2016 Meningitis Collaborators, 2018; Heath et al., 2011;
Molyneux et al., 2015), when mortality is higher (25–58%) in low-
and middle-income countries (LMICs) than in industrialized
countries (6–15%) (Furyk et al., 2011; Gaschignard et al., 2011;ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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58% of patients (Edmond et al., 2010; Furyk et al., 2011; Heath et al.,
2011).
The World Health Organization (WHO) defines a case as
‘neonatal’ when it occurs at 28 days of age, whereas the US
guidelines place the age limit at <90 days (Molyneux et al., 2015).
Furthermore, neonatal BM is deemed ‘early-onset’ if signs appear
at <7 days of age, or as ‘late-onset’ if signs appear at 7–89 days
(Okike et al., 2014).
The diagnosis of BM is especially difficult in small infants whose
symptoms can be subtle and mimic sepsis or other infections
(Furyk et al., 2011; GBD 2016 Meningitis Collaborators, 2018). It is
estimated that 25% of infants with sepsis also have BM (Heath et al.,
2011). Although the global burden of BM at age <90 days is
unknown, the WHO estimated that 402 414 deaths were due to
neonatal sepsis, meningitis, or both in 2015 (World Health
Organization, 2019). Efforts to reduce this burden are particularly
needed in Africa and Asia where the incidence is the highest (GBD
2016 Meningitis Collaborators, 2018GBD 2016 Meningitis Collab-
orators, 2018).
The most common causative agents of neonatal BM in
industrialized countries are Streptococcus agalactiae and Escherichia
coli, whereas in LMICs other gram-negative bacteria, Streptococcus
pneumoniae, Staphylococcus aureus, and Haemophilus influenzae also
appear (Furyk et al., 2011; Okike et al., 2014; Oordt-Speets et al.,
2018). Antimicrobial resistance is also increasing in LMICs (Furyk
et al., 2011; Huynh et al., 2018; Okomo et al., 2019), where laboratory
facilities may be absent or insufficient (Molyneux et al., 2015;
Okomo et al., 2019). However, data on antibiotic susceptibility are
critical for adopting best-treatment strategies for BM.
Angola is a country in Sub-Saharan Africa with a population of
28 million. The population growth rate is 3.3%, and the annual birth
cohort is 1.2 million (Gavi, 2020). Luanda, the capital, has a
population of 2.8 million and an urban area of 8.2 million. The
under-5 mortality rate is 77/1000, the infant mortality rate is 52/
1000, and the neonatal mortality rate is 28/1000; these indices are
among the highest in the world. Approximately 36 000 neonatal
deaths occurred in Angola in 2018 (Unicef, 2020). The pentavalent
and the 13-valent pneumococcal conjugate vaccines were intro-
duced in the country in 2006 and in 2013, respectively. Both are
administered at 2, 4, and 6 months of age (Gavi, 2020). Due to the
minimal data on neonatal BM in Central Africa (Okomo et al., 2019;
Oordt-Speets et al., 2018), this study was performed to examine the
aetiology of BM in Angolan children <90 days of age.
Materials and methods
Setting
Most babies in Luanda are born in maternity hospitals. If health
problems arise, patients may be sent to the Hospital Pediátrico
David Bernardino (HPDB), a 300-bed paediatric referral and
teaching hospital in the city. Most newborn babies and small
infants are taken to HPDB directly from home and only a few are
transferred to this hospital from health centres or other hospitals.
A diagnostic bacteriological laboratory was established in 2002.
During the study, the 30-bed neonatal ward was not yet equipped
with technology for mechanical ventilation of babies. Routine
treatment for BM and neonatal sepsis was a combination of
ampicillin and cefotaxime, and of ampicillin and gentamicin,
respectively.
Study design
This prospective, observational, single-site, and descriptive
study was conducted between February 1, 2016 and October 23,2017. All infants aged <90 days presenting at HPDB who underwent
lumbar puncture (LP) were included in the study. Attending
physicians performed the LPs when there was a suspicion of BM
according to the WHO criteria: acute onset of fever (usually >38.5 
C rectal or 38.0 C axillary), headache, and one of the following
signs: neck stiffness, altered consciousness, or other meningeal
signs (World Health Organization, 2020). Newborn babies also
underwent LP if they presented with a bulging fontanelle or with
other more subtle and non-specific signs like prostration or
irritability and if neonatal sepsis was suspected. There were no
exclusion criteria. Data for older children have been published
before (Urtti et al., 2019).
Macroscopic examination, leukocyte counts, and glucose and
protein concentration measurements were performed for all
cerebrospinal fluid (CSF) specimens. For babies <30 days old,
Gram staining and bacterial culture were always performed,
whereas for older infants these were performed only if CSF
leukocytes were >10/mm3 or the glucose concentration was <25
mg/dl. When available, bacterial antigen testing (latex agglutina-
tion test, Pastorex Meningitis; Bio-Rad Laboratories Inc., Marne-La-
Coquette, France) was conducted if >100 leukocytes/mm3 were
present and bacterial culture was negative.
BM was considered confirmed when bacteria were identified in
the CSF (by culture, Gram stain, antigen detection, or PCR) (World
Health Organization, 2020). BM was considered ‘probable’ when
the CSF was turbid or showed >100 leukocytes/mm3. BM was also
considered probable with milder leukocytosis (10–100 cells/mm3)
if the protein concentration was >100 mg/dl or glucose was <40
mg/dl (World Health Organization, 2020).
Laboratory methods
The CSF specimens were transported to the hospital laboratory
within 3 h of sampling. Based on previously established guidelines
(Cheesbrough, 2000), the CSF was cultured on blood and chocolate
agar plates and incubated accordingly. Bacteria were identified
with standard bacteriological phenotypic methods. Antimicrobial
susceptibility was tested using available discs and applying Clinical
and Laboratory Standards Institute standards (Clinical and
Laboratory Standards Institute, 2007). Whenever possible, the
remainder of the CSF sample was stored at 80 C and later
shipped for PCR identification to the Centre for Respiratory
Diseases and Meningitis (CRDM), National Institute for Communi-
cable Diseases (NICD), Johannesburg, South Africa.
DNA extraction was performed using the MagNA Pure 96
instrument (Roche, Mannheim, Germany) with the Viral NA small
volume kit (Roche). Molecular detection of meningitis pathogens
targeted the ctrA, lytA, and hpd genes for N. meningitidis, S.
pneumoniae, and H. influenzae, respectively, using a multiplex real-
time PCR assay with the Applied Biosystems 7500 Fast real-time
PCR platform (Applied Biosystems, Foster City, CA, USA) (Wang
et al., 2012).
All PCR-positive samples were further serotyped/grouped by
real-time PCR. ctrA-positive samples were confirmed using two
multiplex reactions for the detection of serogroups A, W, X, B, C,
and Y (Mothershed et al., 2004). Serotypes in hpd-positive samples
were determined using three multiplex reactions (Maaroufi et al.,
2007; Wang et al., 2011). lytA-positive samples with cycle
threshold (Ct) values 35 were tested by eight multiplex reactions
detecting 38 serotypes (Magomani et al., 2014; Pimenta et al.,
2013).
Endpoints
The primary objective of this study was to describe the
aetiology of BM in infants <90 days of age. The secondary objective
Table 1
Indications for cerebrospinal fluid sampling in infants aged <90 days.
Reason Number analysed %
Altered level of consciousness 261 25.2
Convulsions 99 9.5
Prostration 96 9.3
Irritability 10 1.0
Bulging fontanelle 6 0.6
Meningism 1 0.1
Neonatal sepsis 563 54.3
Total 1036 100
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information was obtained from specially designed forms complet-
ed by the study nurses and doctors.
Statistical analysis
The data were computed and analysed with StatView version
5.1 (SAS Institute, Cary, NC, USA). The results are presented
descriptively with means, percentages, medians, p-values, and
interquartile ranges (IQRs) where appropriate.
Results
Study population
A total of 4796 children (aged 15 years) with suspected
meningitis were tapped during the study period. Of these, 1287
(26.8%) were aged <90 days (Figure 1) and the main reason for LP
was specified in 1036 cases (Table 1). The CSF characteristics are
summarized in Table 2. There were 299 BM cases, of which 212/
1089 (19.5%) were confirmed cases and 87 (8.0%) were probable
cases.
For the infants with BM, the exact age was recorded as follows:
272 (91%) were <1 month, 21 (7%) were 1 month, and six (2%) were
2 months. One hundred and sixty-five (55%) were female.
Forty percent (57/143) of infants with BM weighed <2500 g. Of
the infants, 11% (21/183) were classified as premature and 26% (47/
183) showed growth failure, while 63% (115/183) were born at term
with appropriate weight.
The outcome was registered for 135 infants with confirmed or
probable BM. Of these, 33 (24%) died.
Aetiology and organism characteristics
Bacteria  were detected in CSF by culture, PCR, latex
agglutination, Gram staining, or combinations thereof in
22.3% (212/949) of cases (Table 3). The CSF culture result was
available in 960 cases, of which 45 (4.7%) showed contamination
and 116 (12.1%) were positive. PCR was performed in 379 cases,
of which 24 (6.3%) were positive and 67 (17.7%) inconclusive.
Latex agglutination was performed in 68 cases, of which 14Figure 1. Flowchart for the inclusion(20.6%) were positive. Gram-staining was performed in 1005
cases, of which 168 (16.7%) were positive.
The most common pathogens were Klebsiella spp in 30 cases
(14.2%), S. pneumoniae in 29 cases (13.7%), S. agalactiae in 20 cases
(9.4%), E. coli in 17 cases (8.0%), and S. aureus in 11 cases (5.2%)
(Table 3 and Figure 2). Of the 13 serotyped strains of S. pneumoniae,
eight were vaccine types (three cases of 23 F, two of 19A, and one
case each of 5, 7F/7A, and 19F). All of these children were too young
to have received a pneumococcal vaccine. H. influenzae was
identified in eight cases (one type a, five type b, and two non-
typeable cases). These five children with H. influenzae type b (Hib)
meningitis were also too young for scheduled vaccination.
Antimicrobial susceptibility
Resources allowed susceptibility testing of 96 isolates for most
relevant antibiotics (Table 4). Among S. pneumoniae, 3/14 (21%)
showed decreased susceptibility to penicillin and one strain was
also resistant to third-generation cephalosporins. Among S. aureus,
4/11 (36%) strains were methicillin-resistant (MRSA). Furthermore,
20 (34%) of the 59 gram-negative bacteria tested were resistant to
third-generation cephalosporins, all being extended-spectrum β-
lactamase (ESBL)-producing isolates. Chloramphenicol resistance
of these strains was 48% (23/48), whereas resistance to gentamicin
(6/45; 13%) and ciprofloxacin (2/46; 4%) was rarer. Klebsiella spp
and E. coli were resistant to third-generation cephalosporins in 11/
24 (46%) and 4/13 (31%) cases, respectively, but less so to
gentamicin (1/18 (6%) and 4/12 (33%), respectively). of cerebrospinal fluid samples.
Table 2
Cerebrospinal fluid characteristics.
Characteristics Number (%), or median (IQR) Bacteria found by No bacteria found p-Value
Culture PCR only Latex only Gram stain only
Gross appearance <0.0001
Clear 376 (40%) 25 8 0 17 326
Xanthochromism 338 (36%) 46 6 3 20 263
Haemorrhagic 179 (19%) 27 5 1 13 133
Turbid 52 (5%) 17 5 7 12 11
Total 945 115 24 11 62 733
Leukocyte number 0 (0–25) 0 (0–75) 0 (0–2) 779 (110–2950) 0 (0–105) 0 (0–2) <0.0001
n = 923
Majority PMN leukocytes 61/114 (54%) 23/27 (85%) 1/2 (50%) 6/8 (75%) 15/18 (83%) 16/59 (27%) <0.0001
Glucose, mg/dl 50 (30–70) 34 (11–58) 49 (35–54) 18 (6–23) 26 (15–50) 53 (34–73) <0.0001
n = 912
Protein, mg/dl 85 (55–144) 125 (60–231) 74 (40–141) 267 (130–286) 105 (69–158) 87 (56–138) <0.0001
n = 805
IQR, interquartile range; PMN, polymorphonuclear.
Table 3
Agents identified in cerebrospinal fluid.
Causative agent Bacteria detected by In all % of total
Culture PCR Latex Gram-stain
Gram-positive bacteria 44 15 11 35 105 49.5
Streptococcus pneumoniae 14 15 29 13.7
Streptococcus pyogenes 2 2 0.92
Streptococcus agalactiae 9 11 20 9.4
Other streptococci 8 8 3.8
Staphylococcus aureus 11 11 5.2
Other gram-positive bacteria 35 35 16.5
Gram-negative bacteria 71 9 27 107 50.5
Haemophilus influenzae
Type a 1 1 0.5
Type b 1 4 5 2.4
Non-typeable 2 2 0.92
Neisseria meningitidis 2 2 0.92
Klebsiella spp 30 30 14.2
Escherichia coli 17 17 8.0
Enterobacter spp 7 7 3.3
Pseudomonas spp 7 7 3.3
Citrobacter spp 4 4 1.9
Proteus spp 2 2 0.92
Shigella spp 2 2 0.92
Salmonella spp 1 1 0.5
Other gram-negative bacilli 27 27 12.7
Total 115 24 11 62 212 100
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The suspicion of BM among the infants <90 days old in this series
was often correct, although only a quarter of children fulfilled the
criteria for confirmed or probable BM. Bacteria were detected in about
20% of the microbiologically analysed CSF samples; gram-negative
bacteriawere more common than gram-positive. Manygram-negative
strains were resistant to third-generation cephalosporins.
Considering all the LPs performed during this study, the culture
identified bacteria in 12% of cases, which is more than in most
other studies on neonatal BM in non-industrialized countries. In
Ethiopia, neonates 28 days with suspected BM showed positive
CSF culture in 5% of cases (56/1189) (Reta and Zeleke, 2016). In Iran,
out of the 415 neonates hospitalized for sepsis, 10% (n = 40) were
diagnosed with meningitis, whereas only 1% (n = 4) had positive
CSF cultures (Khalessi and Afsharkhas, 2014). In Kenya, 1908
infants <60 days old with suspected sepsis or BM had a LP
performed; of these, 75 (3.9%) had a positive CSF culture.
Surprisingly, no more than 161 (8.4%) fulfilled the criteria for
BM (Mwaniki et al., 2011). Such an overview is rarely obtained, as
many studies do not report the total number of CSF samples taken.In this study, PCR detected S. pneumoniae, H. influenzae, and N.
meningitidis, but increased the detection rate by 11% (24/212)
(Table 3). In a Chinese study on 56 neonates with BM, CSF culture
identified five cases (9%), real-time PCR identified 25 cases (45%),
and multiplex PCR-based reverse line blot hybridization identified
16 cases (29%) (Wang et al., 2014). The PCR-based molecular assays
detected seven neonatal BM pathogens and in fact were more
sensitive than culture (Wang et al., 2014). Resources permitting,
rapid PCR-based assays could also be useful in LMICs where culture
facilities are lacking (Bårnes et al., 2018).
The most common aetiological agent observed in the present
study was Klebsiella spp (14.2%). This was also the predominant
isolate (34%) from bacteraemic infections in a large meta-analysis
of invasive bacterial infection in neonates in Central and Southern
Africa (Okomo et al., 2019). For neonatal BM, the pooled pathogen
prevalence was 26% for S. agalactiae (group B Streptococcus, GBS),
18% for S. aureus, 15% for S. pneumoniae, 15% for Klebsiella, and 15%
for E. coli (Okomo et al., 2019). However, most data were from
South Africa and there was considerable heterogeneity between
regions (Okomo et al., 2019). In another meta-analysis of neonatal
BM in Africa, S. pneumoniae was responsible for 20.4% and E. coli for
Figure 2. Causative agents of bacterial meningitis in infants <90 days of age (n = 212).
Table 4
Antibiotic susceptibility of cerebrospinal fluid isolatesa.
Bacteria Total isolates Penicillin Amoxicillin Gentamicin Third-generation cephalosporin Chloramphenicol Ciprofloxacin
Gram-positive bacteria
Streptococcus pneumoniae 14 Penicillin 9/10 (90) 9/14 (64) 1/1 (100)
11/14 (79)
Staphylococcus aureus 11 Oxacillin 2/2 (100) 5/6 (83) 10/11 (91) 8/9 (89)
7/11 (64)
Gram-negative bacteria
Klebsiella spp 30 3/26 (12) 17/18 (94) 13/24 (54) 3/16 (19) 19/19 (100)
Escherichia coli 17 3/17 (18) 8/12 (67) 9/13 (69) 7/13 (54) 9/10 (90)
Pseudomonas spp 7 2/7 (29) 6/7 (86) 4/7 (57) 6/7 (86) 5/5 (100)
Enterobacter spp 7 1/5 (20) 2/2 (100) 6/7 (86) 3/5 (60) 3/4 (75)
Citrobacter spp 4 1/4 (25) 1/1 (100) 1/2 (50) 2/2 (100) 2/2 (100)
Other gram-negative bacteria 6 1/6 (17) 5/5 (100) 6/6 (100) 4/5 (80) 6/6 (100)
All gram-negative bacteria 71 11/65 (17) 39/45 (87) 39/59 (66) 25/48 (52) 44/46 (96)
a Data are number (%). Isolates may have been tested for susceptibility to different antimicrobial agents.
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corresponding figures were 13.7% and 8.0%.
Agents that cause BM (Swann et al., 2014) and other invasive
infections (Okomo et al., 2019) in neonates in Sub-Saharan Africa are
often resistant to the recommended antimicrobials. We observed
more S. pneumoniae strains with reduced susceptibility to penicillin
in Angola than in Malawi (21% vs. 7%) (Swann et al., 2014); one of our
strains was even resistant to third-generation cephalosporins. E. coli
showed resistance to gentamicin and to third-generation cepha-
losporins more often than E. coli in Malawi (33% vs 12%, and 31% vs
0%, respectively) (Swann et al., 2014). In the meta-analysis of
invasive infections, resistance was even more common (47% and
33%, respectively) (Okomo et al., 2019). Klebsiella, the most common
bacterium in our study, showed alarming rates of resistance to
third-generation cephalosporins (46% vs. 35% in Malawi and 49–
78% in the meta-analysis) (Okomo et al., 2019; Swann et al., 2014).
However, resistance to gentamicin was rarer (6% vs 14% vs 66%) and
all strains were susceptible to ciprofloxacin.
The introduction of conjugate vaccines against Hib and S.
pneumoniae decreases the incidence of BM not only in those
vaccinated, but also through herd immunity in non-vaccinated
populations, including infants <2 months of age (GBD Meningitis
Collaborators, 2018; GBD 2016 Meningitis Collaborators, 2018;
Heath et al., 2011; Molyneux et al., 2015; Oordt-Speets et al., 2018).However, BM caused by serotypes not covered by vaccines are
widely reported (GBD 2016 Meningitis Collaborators, 2018GBD
2016 Meningitis Collaborators, 2018). In HPDB, Luanda, 10 years
after the introduction of Hib vaccination, Hib was still identified in
five infants (one infant had BM due to H. influenzae type a and two
infants had non-typeable H. influenzae). Three years after the
introduction of the 13-valent pneumococcal vaccine, S. pneumo-
niae was the second most common agent, despite 62% of the
serotypes being included in the vaccine. Improving the uptake of
both vaccines would also lead to beneficial effects in neonates.
The fatality rate (24%) of BM in this study was probably an
underestimation, as this information was available for only a
fraction of the infants (135/299; 45%). In rural Kenya, LP was not
performed in 81% (466/575) of the infants <60 days old who
ultimately died from likely BM or sepsis (Mwaniki et al., 2011). In
Luanda, many infants also arrived so ill that LP was considered too
risky. Although a questionable decision, these children were not
included in the analysis. Of note is our own finding from the same
hospital that 17% of children with BM died soon after arrival at the
emergency department (Pelkonen et al., 2008). These data were
not available for this study.
This study has some limitations. As the series was collected in a
single hospital in Luanda, the generalizability of the findings is
limited. However, most children in greater Luanda with symptoms
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referred here from other hospitals. We could not distinguish
between community-acquired and hospital-acquired infections.
The study was conducted in an urban setting, and there may be
some differences (such as in aetiological agents) when compared
with a rural setting. CSF culture results were not available for all
patients. The PCR assay used detected S. pneumoniae, H. influenzae,
and N. meningitidis, but no bacteria common in the neonatal
period, such as S. agalactiae or other gram-negative bacteria. One
may thus assume that the role of these other bacteria was
underestimated. Furthermore, economic constraints limited the
taking of blood cultures and antibiotic susceptibility testing of CSF
isolates. Finally, individual patient data were obtained from the
study forms and medical records, which were not always fully
completed. The patients were included in the study at a very busy
emergency department, which could have resulted in imprecise
recording of the patient data.
Despite these limitations, we believe that the message of this
study remains valid. BM is common among infants <90 days old in
Luanda, and this potentially fatal disease is primarily caused by
gram-negative bacteria that often are multiresistant. Continued
surveillance of the agents and their susceptibility patterns is
essential in order to provide the best available treatment.
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